Print-friendly View
Resources for Health Professionals and Patients
| Review: The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial | |
Attached file: |
(Russian, 282 kb)
Review: The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
|
Link to document(s) | http://www.ncbi.nlm.nih.gov... |
Author(s): | Eron J. et al. |
Document type: | Literature Reviews |
Language: | English, Russian |
Original language of document: | Russian |
Publication date: | August 5, 2006 |
Primary area(s) of focus: | HIV/AIDS |
Secondary areas of focus: | Adherence to treatment regimens, Clinical trials, Comprehensive Care and Support |
Submited by: | Victor Stanilevskiy |
Material written specifically for patients: | No |
Date of entry: | October 11, 2006 |
Pages: | 2 |
| This article review was prepared by the Internet project MedMir.com, which is aimed to provide Russian speaking medical professionals with timely, comprehensive and relevant clinical information in the form of the Russian language summaries of clinical study reports published in the top world medical journals. | |
Overall user rating: | Not yet reviewed |
